Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -0.73% | 126.63 | 0.6% | $865.71m | |
| ABBV | AbbVie, Inc. | -0.52% | 92.53 | 2.1% | $787.66m | |
| MRK | Merck & Co., Inc. | 0.41% | 58.88 | 0.6% | $737.02m | |
| PFE | Pfizer Inc. | 0.30% | 36.64 | 0.8% | $736.77m | |
| BMY | Bristol-Myers Squibb Company | -0.81% | 51.19 | 1.4% | $515.80m | |
| LLY | Eli Lilly and Company | -0.70% | 79.19 | 1.0% | $286.20m | |
| NVS | Novartis AG Sponsored ADR | -1.28% | 77.99 | 0.2% | $153.10m | |
| AZN | AstraZeneca PLC Sponsored ADR | -0.20% | 35.33 | 1.3% | $150.46m | |
| GSK | GlaxoSmithKline plc Sponsored ADR | 0.48% | 40.07 | 0.2% | $140.55m | |
| NVO | Novo Nordisk A/S Sponsored ADR Class B | -0.60% | 47.38 | 0.1% | $52.23m | |
| SNY | Sanofi Sponsored ADR | -0.46% | 39.98 | 0.2% | $51.14m | |
| LCI | Lannett Company, Inc. | 1.20% | 16.85 | 38.1% | $10.95m | |
| AKTX | Akari Therapeutics Plc Sponsored ADR | -0.50% | 1.99 | 1.7% | $0.18m | |
| EPIX | ESSA Pharma Inc | -4.79% | 0.16 | 0.0% | $0.02m |
Company Profile
GenVec, Inc. is a clinical-stage gene delivery company, which engages in the development of therapeutics and vaccines. The firm designs, tests, and manufactures adenoviral-based product candidates using its proprietary AdenoVerse platform. Its products include CGF166-Hearing Loss; GV2311-RSV Vaccine; and GV2207-HSV-2 Immunotherapeutic. The company was founded in December 1992 and is headquartered in Gaithersburg, MD.